U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine

info
Case Update June 13, 2024
The U.S. Supreme Court declined to address the FDA’s reckless removal of safety standards for abortion drugs. We will be evaluating our options in the lower courts as we continue to advocate for women’s health and expose the FDA’s reckless actions.
Read the Press Release arrow_right_alt
U.S. Supreme Court

U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine

The FDA Endangered Women's Health by Removing Key Safeguards for High-Risk Abortion Drugs

We Explain the Case
TBD

Case Summary

spacer

When the FDA recklessly removed safety standards for high-risk abortion drugs, it put women in danger. ADF attorneys are asking the Supreme Court to affirm what two lower courts have already found: the FDA acted unlawfully when it removed these crucial safeguards.

Read More About the Case
Coming Soon
Oral Arguments Livestream
Tuesday, March 26, 2024
9:45 AM ET
Listen Now
Oral Arguments Livestream Replay
Play

Behind the Case

Doctors are standing up to the FDA, holding it accountable for endangering women and girls by abandoning safeguards for abortion drugs, including in-person visits with a doctor to check for ectopic pregnancies, severe bleeding, and life-threatening infections.

Dr. Susan Bane, MD, PhD Play Button TBD
video
Doctors to FDA: Restore Critical Abortion Drug Safeguards
Play Button College student being interviewed
video
UT Austin Students Discuss FDA's Removal of Abortion Drug Safeguards
Elizabeth Gillette
article
I Was Told Abortion Drugs Wouldn't Hurt Me. It Was a Lie.
TBD Play Button TBD
video
Abortion Drugs are High-Risk

FAQs

  • The FDA's own label says that roughly one in 25 women who take abortion drugs will end up in the emergency room. Women can face excruciating pain, severe bleeding for weeks on end, and life-threatening infections, which is why the ongoing, in-person care of a doctor is critical.

  • No. This case has nothing to do with contraception or Plan B. This case is about making sure the FDA reinstates the safeguards it deemed necessary for women and girls who use the abortion drug mifepristone during the first trimester of their pregnancies. We are asking the Court to hold the FDA accountable for its reckless removal of critical safety standards around chemical abortion drugs.

  • Absolutely not. The FDA's own labels warns that roughly one in 25 women who take abortion drugs will end up in the emergency room. That doesn’t happen from taking a Tylenol or Advil.

  • ADF has never relied on these studies for the issues that are currently before the Court. So the retractions will not have any effect on the Court's consideration. Regardless, it was wrong for Sage to withdraw research that does not fit a preferred narrative and retract these articles without advancing a valid objection to the findings and no legitimate reason for these retractions.

Kelly Lester is standing up for women after she experienced the harms of abortion drugs.
Kelly Lester is standing up for women after she experienced the harms of abortion drugs.
giving

Join the Team

Do you want to support our work? Your gift helps us take on more cases that reshape the legal landscape and reorients the culture to protect women and girls from harm.